Publisher： Bentham Science Publishers
E-ISSN： 2212-3873|16|1|32-38
ISSN： 1871-5303
Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.16, Iss.1, 2016-03, pp. : 32-38
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Zoledronic Acid: A Review of its Use in the Treatment of Osteoporosis
By Deeks Emma D. Perry Caroline M.
Drugs & Aging, Vol. 25, Iss. 11, 2008-01 ,pp. :
Access to resources
Recommend
Zoledronic acid reduces recurrence risk in women with EBC
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :
Aspirin fails to prevent cognitive decline in elderly women
Inpharma, Vol. 1, Iss. 1586, 2007-01 ,pp. :
Zoledronic acid for prevention and treatment of osteoporosis
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 5, 2011-04 ,pp. :